Clinical significance of serum human papillomavirus DNA in cervical carcinoma

By Hsu K.-F.   Huang S.-C.   Hsiao J.-R.   Cheng Y.-M.   Wang S.P.H.   Chou C.-Y.  

Obstetrics and Gynecology, Vol. 102, Iss. 6, 2003-12 ,pp. : 1344-1351

Elsevier

Access to resources Recommend Favorite

In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer

By Wang Hua   Xu Hui   Lu Wei   Zhu Lin   Yu Yun   Hong Fan  

Archives of Gynecology and Obstetrics, Vol. 289, Iss. 1, 2014-01 ,pp. : 155-162

Springer Publishing Company

Access to resources Recommend Favorite

Poor clinical outcome in early stage cervical cancer with human papillomavirus-18 positive lymph nodes

By Sapy T.   Hernadi Z.   Konya J.   Lukacsko L.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 90, Iss. 1, 2000-05 ,pp. : 93-95

Elsevier

Access to resources Recommend Favorite

Human papillomavirus and control of cervical cancer in India

By Bharti Alok C   Shukla Shirish   Mahata Sutapa   Hedau Suresh   Das Bhudev C  

Expert Review of Obstretrics and Gynecology, Vol. 5, Iss. 3, 2010-05 ,pp. : 329-346

Informa Healthcare

Access to resources Recommend Favorite

Human papillomavirus and cervical cancer: where are we now?

By Kirwan J.M.J.   Herrington C.S.  

British Journal of Obstetrics and Gynaecology, Vol. 108, Iss. 12, 2001-12 ,pp. : 1204-1213

Elsevier

Access to resources Recommend Favorite